About Event

So, What's New for 2025?

Interactive Workshop Exploring Cell-Free DNA

Lizzie - Conference Logos (1)

Starting the morning with a bang, experts from Pfizer and Beam Therapeutics will be sharing their experience with cell-free DNA.

Comparing DNA quality, stability and immunogenicity, as well as overall timescale, cost and efficiency, this session will delve into the challenges and innovations of a cell-free approach.

Bring your curiosity and ask your burning questions on transitioning away from traditional pDNA, and share the experience you have with cell-free DNA as we unravel the possibilities and limitations of this exciting approach.

Get firsthand insight from pharma giants Sanofi, AstraZeneca, and Pfizer, who will be discussing advances in off-the-shelf lysis equipment, advanced purification technologies, and chromatography techniques beyond traditional resin-based approaches.

Quiz the experts on the latest techniques to bring back to your own downstream process development to streamline your DNA production.

Pharma-led Fireside Chat: Optimizing Downstream DNA Process Development

Lizzie - Conference Logos (2)

Refreshed Speaker Faculty & New Expert Companies Attending – Brand new speakers including:

Lizzie - Conference Logos (3)

Zsolt Gengeliczki, Associate Director, Analytical Project Lead, Novartis

Mark Geng, Director, Global DS MS&T DNA Lead Moderna

Taesun Eom, Director, RNA Technologies, Chroma Medicine

Jennifer Lin, Director, Preclinical MFG, Beam Therapeutics

James Osborn, Senior Scientist, Preclinical Development, Merck

Brian Korniski, Senior Principal Scientist, Pfizer

Angel Tai, Manager, External QA Operations, Sanofi

Hui Zhi, Principal Scientist, mRNA Process Development, Beam Therapeutics

Suriyasri Subramanian, Senior Scientist, AstraZeneca

Connect with us - join the LinkedIn community

Are you looking to meet your fellow Directors, Heads, and Principal Scientists invested in DNA process development, analytical development, regulatory affairs, and CMC?

Join us as this niche community of large pharma and innovative biotech gathers over 3 days to assess the emerging technologies in the field, take back actionable insights to your team, and meet the rising demand for DNA production.

EXPERT SPEAKER FACULTY
2025 EVENT GUIDE

What Your Peers Have to Say:

“The meeting offers experts a valuable opportunity to exchange knowledge on the latest advancements in DNA manufacturing, engage in discussions surrounding technical challenges, and gain a better understanding of regulatory expectations” – Associate Director, Novartis

“This meeting is a great opportunity for people to learn from each other and to help get over the challenges in the field. These efforts will help advance the field forward” – Director, RNA Technologies, Chroma Medicine

“Engaging with leaders in the field allows for fruitful discussions, fostering collaborations and partnerships that could accelerate the development of new technologies" – Chief Technology Officer, Mediphage Bioceuticals

“Learn from other industry leaders on DNA strategies, development, and manufacturing practices and advance the industry understanding on DNA as a starting material for biologics" – Director, Moderna
REGISTER
FULL EVENT GUIDE
PARTNER
BACK TO THE TOP